Management of Prolonged COVID-19 Infection with Persistent Symptoms at 1 Month

Immediate Assessment and Diagnostic Workup

The British Medical Journal recommends urgent referral to acute services if the patient exhibits severe hypoxemia, signs of severe lung disease, cardiac chest pain, respiratory rate >30 breaths/minute, or oxygen saturation ≤93% at rest 2
The Clinical Microbiology and Infection journal suggests assessing for serious complications that require immediate intervention, including thromboembolic events, myocarditis, encephalitis, and previously overlooked malignancy 3
A detailed history should be obtained to exclude pre-existing underlying conditions, iatrogenic causes, and complications directly related to the acute infection episode, as recommended by the Clinical Microbiology and Infection journal 1, 3
The BMJ recommends documenting specific symptoms and their impact, including fatigue severity, dyspnea, cognitive impairment, dysautonomia symptoms, pain locations, and smell and taste alterations 2, 3

The Clinical Microbiology and Infection journal recommends ordering a basic panel of laboratory tests, including complete blood count, C-reactive protein, kidney function tests, and liver function tests 1, 2, 3
The BMJ suggests considering symptom-specific additional testing, such as troponin, CPK-MB, and B-type natriuretic peptide for cardiac symptoms, and complete thyroid function tests for suspected thyroiditis 2, 3
The Clinical Microbiology and Infection journal recommends avoiding unnecessary testing, such as D-dimer in patients without respiratory symptoms, and blood gases with limited benefit even with decreased oxygen saturation 1, 2, 3

The BMJ recommends validating the patient's experience and providing reassurance that symptoms are being taken seriously, as well as acknowledging uncertainties in the field while providing evidence-based guidance 2, 3
The Clinical Microbiology and Infection journal suggests implementing energy conservation strategies and pacing techniques, and setting realistic, achievable goals based on current activity tolerance 1, 2, 3
The BMJ recommends providing self-management guidance, including ways to self-manage symptoms, symptom tracking, and sources of support, as well as considering multidisciplinary rehabilitation for physical, psychological, and cognitive support 2, 3

The Clinical Microbiology and Infection journal notes that no medications are specifically approved for Long COVID, and medication use should follow standard practice for symptom management, with caution and shared decision-making 3
The BMJ recommends treating comorbidities and modifiable risk factors according to standard guidelines, and exercising caution with medications that may improve some symptoms but worsen others 2, 3

The BMJ recommends establishing a clear follow-up plan, including frequency of follow-up, involved healthcare professionals, and monitoring for symptom progression or new complications 2, 3
The Clinical Microbiology and Infection journal suggests planning for reassessment at 12 weeks, with consideration of formal diagnosis of Long COVID, routine pulmonary function testing, and chest imaging for respiratory symptoms 1, 2, 3, 4

The BMJ recommends addressing work capacity early, discussing phased return to work or education, and identifying suitable workplace accommodations, as well as considering occupational or vocational therapy referral 2, 3
The Clinical Microbiology and Infection journal notes that Long COVID is recognized as a potential disability under the Americans with Disabilities Act, and disability application may be warranted if work significantly worsens symptoms or impedes recovery 2, 3